SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $116,000 | -93.2% | 595 | -96.0% | 0.00% | -91.7% |
| Q4 2019 | $1,711,000 | +41.2% | 14,969 | +5.6% | 0.01% | +33.3% |
| Q3 2019 | $1,212,000 | +25.7% | 14,181 | +1.8% | 0.01% | +12.5% |
| Q2 2019 | $964,000 | -5.5% | 13,930 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,020,000 | +2900.0% | 13,930 | +2033.2% | 0.01% | – |
| Q2 2017 | $34,000 | -17.1% | 653 | 0.0% | 0.00% | – |
| Q1 2017 | $41,000 | +20.6% | 653 | 0.0% | 0.00% | – |
| Q4 2016 | $34,000 | – | 653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |